- Home
- STI vs CSCI Comparison
STI vs CSCI Comparison
Compare STI & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STI
- CSCI
- Stock Information
- Founded
- STI 2014
- CSCI 1990
- Country
- STI United States
- CSCI Canada
- Employees
- STI N/A
- CSCI N/A
- Industry
- STI
- CSCI
- Sector
- STI
- CSCI
- Exchange
- STI NYSE
- CSCI NYSE
- Market Cap
- STI 9.5M
- CSCI 10.6M
- IPO Year
- STI N/A
- CSCI 1996
- Fundamental
- Price
- STI $4.50
- CSCI $3.90
- Analyst Decision
- STI
- CSCI
- Analyst Count
- STI 0
- CSCI 0
- Target Price
- STI N/A
- CSCI N/A
- AVG Volume (30 Days)
- STI 60.8K
- CSCI 5.2K
- Earning Date
- STI 08-12-2025
- CSCI 08-12-2025
- Dividend Yield
- STI N/A
- CSCI N/A
- EPS Growth
- STI N/A
- CSCI N/A
- EPS
- STI 6.72
- CSCI N/A
- Revenue
- STI N/A
- CSCI $9,030,000.00
- Revenue This Year
- STI N/A
- CSCI N/A
- Revenue Next Year
- STI N/A
- CSCI N/A
- P/E Ratio
- STI $0.67
- CSCI N/A
- Revenue Growth
- STI N/A
- CSCI 36.51
- 52 Week Low
- STI $2.94
- CSCI $1.96
- 52 Week High
- STI $55.00
- CSCI $6.77
- Technical
- Relative Strength Index (RSI)
- STI 51.66
- CSCI N/A
- Support Level
- STI $4.22
- CSCI N/A
- Resistance Level
- STI $5.59
- CSCI N/A
- Average True Range (ATR)
- STI 0.41
- CSCI 0.00
- MACD
- STI 0.01
- CSCI 0.00
- Stochastic Oscillator
- STI 24.78
- CSCI 0.00
About STI SOLIDION TECHNOLOGY INC
Solidion Technology Inc is engaged in researching, developing and manufacturing battery materials and components, as well as the development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. It is recognized as a IP leader in both the high-capacity anode and the high-energy solid-state battery.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.